Etop Ibcsg Partners Foundation

This study is testing whether adding two drugs (amivantamab and bevacizumab) to a continued targeted therapy (lazertinib) can help control advanced lung cancer that has started growing again after previous treatment. It will involve about 60 patients with a specific genetic chang…

This trial is testing a pill called adagrasib for people with advanced lung cancer that has a specific genetic change called KRAS G12C. It focuses on patients who are 70 or older or who are in poorer health, groups often left out of other studies. The main goal is to see if the p…

This trial is testing if a powerful combination of immunotherapy, chemotherapy, and precise radiation can control advanced lung cancer that has spread to only a few other body sites. The goal is to stop the cancer from progressing further and improve survival. About 96 patients w…

This study investigates whether young women with hormone-sensitive early breast cancer can safely pause their hormone-blocking therapy to try to become pregnant. It follows over 500 participants to see if this treatment break increases the risk of the cancer coming back. The rese…